| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
VectivBio Holding AG (NASDAQ: VECT)
VECT Technical Analysis
5
| As on 9th Jun 2023 VECT STOCK Price closed @ 16.71 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 5.74 & Strong Buy for SHORT-TERM with Stoploss of 5.14 we also expect STOCK to react on Following IMPORTANT LEVELS. |
VECTSTOCK Price
| Open | 16.70 | Change | Price | % |
| High | 16.78 | 1 Day | 0.02 | 0.12 |
| Low | 16.68 | 1 Week | 0.16 | 0.97 |
| Close | 16.71 | 1 Month | 5.78 | 52.88 |
| Volume | 422218 | 1 Year | 12.20 | 270.51 |
| 52 Week High 16.67 | 52 Week Low 4.20 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| VECT Daily Charts |
VECT Intraday Charts |
Whats New @ Bazaartrend |
VECT Free Analysis |
|
|
VECT Important Levels Intraday
| RESISTANCE | 16.90 |
| RESISTANCE | 16.84 |
| RESISTANCE | 16.80 |
| RESISTANCE | 16.76 |
| SUPPORT | 16.66 |
| SUPPORT | 16.62 |
| SUPPORT | 16.58 |
| SUPPORT | 16.52 |
VECT Forecast May 2024
| 4th UP Forecast | 19.66 |
| 3rd UP Forecast | 18.71 |
| 2nd UP Forecast | 18.13 |
| 1st UP Forecast | 17.54 |
| 1st DOWN Forecast | 15.88 |
| 2nd DOWN Forecast | 15.29 |
| 3rd DOWN Forecast | 14.71 |
| 4th DOWN Forecast | 13.76 |
VECT Weekly Forecast
| 4th UP Forecast | 18.71 |
| 3rd UP Forecast | 18.07 |
| 2nd UP Forecast | 17.67 |
| 1st UP Forecast | 17.28 |
| 1st DOWN Forecast | 16.14 |
| 2nd DOWN Forecast | 15.75 |
| 3rd DOWN Forecast | 15.35 |
| 4th DOWN Forecast | 14.71 |
VECT Forecast2024
| 4th UP Forecast | 41.7 |
| 3rd UP Forecast | 33.69 |
| 2nd UP Forecast | 28.73 |
| 1st UP Forecast | 23.78 |
| 1st DOWN Forecast | 9.64 |
| 2nd DOWN Forecast | 4.69 |
| 3rd DOWN Forecast | -0.27 |
| 4th DOWN Forecast | -8.28 |
VectivBio Holding AG ( NASDAQ USA Symbol : VECT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
VECT Business Profile
VectivBio Holding AG, a clinical stage biopharmaceutical company, focuses on the discovery, development, and commercialization of treatments for rare conditions. It develops Apraglutide, a long-acting synthetic peptide analog of glucagon-like peptide-2 that is in Phase III clinical trial for the treatment of patients with short bowel syndrome-intestinal failure (SBS-IF), as well as for SBS-IF in patients with colon-in-continuity anatomy. The company was incorporated in 2019 and is headquartered in Basel, Switzerland. Address: Aeschenvorstadt 36, Basel, Switzerland, 4051
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service